altretamine

(redirected from Hexalen)

altretamine

 [al-tret´ah-mēn]
an antineoplastic agent used in the palliative treatment of ovarian carcinoma. It is structurally related to an alkylating agent but does not act as one; its exact mechanism is unknown. Administered orally.

altretamine

/al·tret·amine/ (al-tret´ah-mēn) an antineoplastic agent used in the palliative treatment of ovarian cancer.

altretamine

an antineoplastic agent.
indications It is used for the palliative treatment of recurrent, persistent ovarian cancer after induction therapy agent.
contraindications< Known hypersensitivity to this drug, severe bone marrow depression, severe neurological toxicity, and pregnancy prohibit its use.
adverse effects Among the more serious adverse reactions are hepatic toxicity, leukopenia, thrombocytopenia, and anemia.

altretamine

Hexalen Oncology An alkylating anticancer agent. See Chemotherapy.

altretamine

An anticancer drug used to treat advanced caner of the ovary.

altretamine

an antineoplastic agent, similar to tretamine.
References in periodicals archive ?
USPRwire, Tue Dec 08 2015] Adult mouth care is a category which comprises various different types of products, such as mouth antiseptics, including the Hexalen and Betadine brands, and dental care products, including Plak Out.
Drugs that have reached the market with no listed patents, but only regulatory exclusivity, include: Mefloquine HCl (mefloquine hydrochloride), Clozaril (clozapine), Hexalen (altretamine), Leustatin (cladribine), Trasylol (aprotinin bovine), Sclerosol (talc), and Ellence (epirubicin hydrochloride).